Cellini et al. showed that the use of subtenon injections of IFNα-2a is effective at treating diabetic macular edema that is refractory to laser grid treatment and intravitreal injections of triamcinolone, with no adverse events recorded [12]. Here, IFNA2 is linked to diabetic macular edema.